ebomi
Colour theme
Sign in
Insider · CIK 0001291804

George Jean

CIK 0001291804 Name as filed on the most recent filing

Filed as George Jean (20)

66 transaction lines · from 20 filings · filed 2005-06-22 to 2025-08-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

35 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-08-01 P, Open-market purchase Shoulder Innovations, Inc.SI 3,999,990, acquired Open Form 4 filing 0001641172-25-022247
2021-12-13 S, Open-market sale ALX Oncology Holdings IncALXO 12 lines 1,287,431, disposed Open Form 4 filing 0001209191-21-069867
2021-12-10 S, Open-market sale ALX Oncology Holdings IncALXO 6 lines 822,719, disposed Open Form 4 filing 0001209191-21-069135
2021-12-09 S, Open-market sale ALX Oncology Holdings IncALXO 6 lines 2,463,502, disposed Open Form 4 filing 0001209191-21-069135
2021-12-08 S, Open-market sale ALX Oncology Holdings IncALXO 4 lines 1,411,871, disposed Open Form 4 filing 0001209191-21-069135
2020-07-21 P, Open-market purchase ALX Oncology Holdings IncALXO 2 lines 7,600,000, acquired Open Form 4 filing 0000899243-20-020030
2019-06-28 S, Open-market sale Acceleron Pharma IncXLRN 486,300, disposed Open Form 4 filing 0001209191-19-039550
2019-06-26 S, Open-market sale Acceleron Pharma IncXLRN 1,005,942, disposed Open Form 4 filing 0001209191-19-039550
2017-12-15 S, Open-market sale Acceleron Pharma IncXLRN 3,756,009, disposed Open Form 4 filing 0001209191-17-066163
2016-11-17 S, Open-market sale Acceleron Pharma IncXLRN 2 lines 16,047,318, disposed Open Form 4 filing 0001209191-16-151236
2016-11-16 S, Open-market sale Acceleron Pharma IncXLRN 1,362,931, disposed Open Form 4 filing 0001209191-16-151236
2016-09-30 S, Open-market sale Acceleron Pharma IncXLRN 30,428,648, disposed Open Form 4 filing 0001209191-16-144718
2015-06-30 P, Open-market purchase Catabasis Pharmaceuticals IncCATB 3 lines 3,105,312, acquired Open Form 4 filing 0001104659-15-049023
2015-01-15 S, Open-market sale Zeltiq Aesthetics IncZLTQ 511,490, disposed Open Form 4 filing 0001209191-15-004612
2014-12-09 S, Open-market sale Acceleron Pharma IncXLRN 352,086, disposed Open Form 4 filing 0001209191-14-074229
2014-12-08 S, Open-market sale Acceleron Pharma IncXLRN 2 lines 4,021,338, disposed Open Form 4 filing 0001209191-14-074229
2014-11-03 S, Open-market sale Zeltiq Aesthetics IncZLTQ 439,629, disposed Open Form 4 filing 0001209191-14-066387
2014-10-07 P, Open-market purchase Calithera Biosciences, Inc.CALA 3,000,000, acquired Open Form 4 filing 0001209191-14-062654
2014-07-31 S, Open-market sale Zeltiq Aesthetics IncZLTQ 2 lines 585,779, disposed Open Form 4 filing 0001209191-14-049782
2014-06-26 S, Open-market sale Acceleron Pharma IncXLRN 361,303, disposed Open Form 4 filing 0001209191-14-044176

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 25
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. George Jean, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001291804

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.